Lung Cancer
📧 Sign up to get email alerts when something new happens for Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC [Phase 2]
Phase 2 trial evaluating tislelizumab with sitravatinib as maintenance therapy for extensive-stage small cell lung cancer (ES-SCLC).
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations [Phase 2]
Phase 2 clinical trial evaluating the combination of sintilimab and anlotinib in advanced non-small cell lung cancer with EGFR uncommon muta…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018) [Phase 3]
Phase 3 clinical trial investigating selective lymph node dissection for early-stage invasive non-small cell lung cancer (cT1N0M0, CTR>0.5) …
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer [Phase 2, Phase 3]
A clinical trial update exploring radiotherapy in combination with almonertinib for stage III EGFR-mutated lung cancer (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Adjuvant Chemotherapy for High Risk Stage I Lung Adenocarcinoma [Phase 2, Phase 3]
A clinical trial update on adjuvant chemotherapy for high-risk stage I lung adenocarcinoma across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial investigating LMB-100 followed by pembrolizumab in adults with mesothelin-expressing non-squamous non-small cell lung cancer; …
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating FLT3 ligand and CD40 agonist antibody with stereotactic radiotherapy for lung cancer (non-small cell/non…
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Plasmodium Immunotherapy for Lung Cancer [Phase 1, Phase 2]
A clinical trial update on a plasmodium immunotherapy approach for lung cancer, currently in Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers [Phase 4]
Phase 4 trial investigating safety of nivolumab in combination with ipilimumab for advanced cancers; completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial comparing two combination chemotherapy regimens for treating lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy [Phase 2]
Phase 2 trial update for ADMIRAL evaluating adaptive mediastinal radiation with chemo-immunotherapy in locally advanced non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating the abscopal effect of radiation in combination with rhGM-CSF for metastatic non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study [Phase 3]
Phase 3 trial investigating precision exercise prescription for lung cancer patients undergoing surgery has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity [Phase 1, Phase 2]
Clinical trial exploring risk factors of immune checkpoint inhibitor–mediated liver, GI, endocrine, and skin toxicity across early-phase tri…
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: UNITO-001- Study in HRR/PDL1 Positive MPM/NSCLC [Phase 2]
Phase 2 trial update for UNITO-001 in HRR/PD-L1 positive malignant pleural mesothelioma and non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) [Phase 1, Phase 2]
Phase 1/2 study evaluating Epacadostat in combination with Nivolumab in select advanced cancers; results have been posted following completi…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Curative Effect and Quality of Life Between Uniportal and Open Sleeve Lobectomy for Central Type Lung Cancer [Phase 3]
A Phase 3 trial comparing uniportal versus open sleeve lobectomy for central-type lung cancer, focusing on curative effect and quality of li…
-
CLINICAL_TRIALS trial_result · 2023-04-24Clinical Trial Update: Giving Information Systematically and Transparently in Lung and GI Cancer Phase 2 [NA]
A Phase 2 clinical trial update on systematically and transparently providing information in patients with lung and gastrointestinal cancer,…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Aumolertinib Adjuvant Therapy of Resectable Stage I EGFRm+ NSCLC With High-grade Patterns [Phase 2]
A phase 2 clinical trial exploring adjuvant aumolertinib after resection for resectable stage I EGFRm+ non-small cell lung cancer with high-…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer [NA]
Clinical trial update for M5A, a Copper-64 labeled anti-CEA monoclonal antibody used in PET imaging to diagnose CEA-positive cancers; the st…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Giving Information Systematically and Transparently in Lung and GI Cancer Phase 1
Phase 1 clinical trial on systematic and transparent information provision in lung and gastrointestinal cancer settings has completed with r…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer [Phase 1]
Phase 1 trial evaluating a MUC1 vaccine to prevent lung cancer in current and former smokers at high risk; results were posted in 2023-04-19…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer [Phase 1, Phase 2]
Early-phase trial update on a CEA-targeted CAR-T therapy for relapsed/refractory CEA-positive solid tumors, including lung and colorectal ca…